The University of Queensland’s BASE facility – within the AIBN – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate a patch-based mRNA vaccine for COVID-19.
AIBN researcher Dr Sophia Luikinga is following in the footsteps of her MND research mentor after winning a prestigious fellowship to address the neurodegenerative condition from a new angle.
Since 2004, the Australian Institute for Bioengineering and Nanotechnology (AIBN) has made a name for itself as the place that combines researchers, industry and government to solve the world’s biggest problems.
A nanocoating that can halt viral outbreaks and new materials for solar cell and light emitting technology are among the cutting-edge AIBN projects to win funding in the latest Discovery Projects scheme.
You’ll find it in potatoes, bread, and rice, and maybe in a freshly ironed shirt. Now researchers from the AIBN are examining how starch could be a key ingredient in a new generation of bioplastics.
Dr Miaoqiang Lyu is working on an ink formula that could screen print better zinc batteries: flexible power sources that are stronger, cheaper and – crucially - rechargeable.
Cheaper and more efficient solar cells for households and commercial applications are a step closer thanks to new research that will help prove the stability and longevity of this emerging technology.
AIBN researchers have secured a major grant to position lignin as a key plank in the $15 billion market for sustainable rubbers, adhesives, and coatings.
With the support of the Lily Foundation, University of Cambridge Neurologist Dr Jelle van den Ameele and AIBN group leader Dr Seth Cheetham are hoping to change the fortunes of those born with a fatal condition.
From paper aeroplanes to angry polymers and antimicrobial coatings, AIBN research rose to the top during UQ's Three Minute Thesis (3MT) competition in 2024.